Erythropoiesis stimulating agents: approaches to modulate activity

References

• AaproMEmerging topics in anaemia and cancerAnn Oncol201223Suppl 10x289x29322987979
   PubMed Web of Science ®Google Scholar
• ElliottSSinclairAMThe effect of erythropoietin on normal and neoplastic cellsBiologics2012616318922848149
   PubMedGoogle Scholar
• MolineuxGSinclairABiology of erythropoietinParnhamMJBruinvelsJErythropoietins, Erythropoietic Factors, and Erythropoiesis2nd edBaselBirkhauser20094160
   Google Scholar
• MuchnikEKaplanJHIF prolyl hydroxylase inhibitors for anemiaExpert Opin Investig Drugs2011205645656
   PubMed Web of Science ®Google Scholar
• ConstantinescuSNKerenTSocolovskyMNamHHenisYILodishHFLigand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domainProc Natl Acad Sci USA20019884379438411296286
   PubMed Web of Science ®Google Scholar
• PhiloJSAokiKHArakawaTNarhiLOWenJDimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interactionBiochemistry1996635168116918634300
   PubMed Web of Science ®Google Scholar
• Supino-RosinLYoshimuraAAltaratzHNeumannDA cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradationEur J Biochem1999263241041910406949
   PubMedGoogle Scholar
• HiltonDJWatowichSSMurrayPJLodishHFIncreased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptorProc Natl Acad Sci USA19959211901947816815
   PubMed Web of Science ®Google Scholar
• NeumannDWikstromLWatowichSSLodishHFIntermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomesJ Biol Chem19932681813639136498514796
   PubMed Web of Science ®Google Scholar
• MeyerLDeauBForejtnikovaHbeta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferationBlood2007109125215522217327410
   PubMed Web of Science ®Google Scholar
• WalrafenPVerdierFKadriZChretienSLacombeCMayeuxPBoth proteasomes and lysosomes degrade the activated erythropoietin receptorBlood2005105260060815358619
   PubMed Web of Science ®Google Scholar
• HuangLJConstantinescuSNLodishHFThe N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptorMol Cell2001861327133811779507
   PubMed Web of Science ®Google Scholar
• SeubertNRoyerYStaerkJActive and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimerMol Cell20031251239125014636581
   PubMed Web of Science ®Google Scholar
• WojchowskiDMGregoryRCMillerCPPanditAKPircherTJSignal transduction in the erythropoietin receptor systemExp Cell Res1999253114315610579919
   PubMed Web of Science ®Google Scholar
• WojchowskiDMSathyanarayanaPDevAErythropoietin receptor response circuitsCurr Opin Hematol201017316917620173635
   PubMed Web of Science ®Google Scholar
• MinooPZadehMMRottapelRLebrunJJAliSA novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signalingBlood200410341398140714551136
   PubMed Web of Science ®Google Scholar
• JegalianAGWuHDifferential roles of SOCS family members in EpoR signal transductionJ Interferon Cytokine Res200222885386012396724
   PubMed Web of Science ®Google Scholar
• de la ChapelleATraskelinALJuvonenETruncated erythropoietin receptor causes dominantly inherited benign human erythrocytosisProc Natl Acad Sci USA19939010449544998506290
   PubMed Web of Science ®Google Scholar
• ArcasoyMOKarayalAFSegalHMSinningJGForgetBGA novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosisBlood2002a9983066306911929803
   PubMed Web of Science ®Google Scholar
• JacobsKShoemakerCRudersdorfRIsolation and characterization of genomic and cDNA clones of human erythropoietinNature198531360058068103838366
   PubMed Web of Science ®Google Scholar
• LinFKSuggsSLinCHCloning and expression of the human erythropoietin geneProc Natl Acad Sci USA19858222758075843865178
   PubMed Web of Science ®Google Scholar
• DavisJMArakawaTStricklandTWYphantisDACharacterization of recombinant human erythropoietin produced in Chinese hamster ovary cellsBiochemistry1987269263326383607040
   PubMed Web of Science ®Google Scholar
• BrowneJKCohenAMEgrieJCErythropoietin: gene cloning, protein structure, and biological propertiesCold Spring Harb Symp Quant Biol198651Pt 16937023472747
   PubMedGoogle Scholar
• EgrieJCBrowneJLaiPLinFKCharacterization of recombinant monkey and human erythropoietinProg Clin Biol Res19851913393502996025
   PubMedGoogle Scholar
• RuddPMDwekRAGlycosylation: heterogeneity and the 3D structure of proteinsCrit Rev Biochem Mol Biol199732111009063619
   PubMed Web of Science ®Google Scholar
• SasakiHBothnerBDellAFukudaMCarbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNAJ Biol Chem19872622512059120763624248
   PubMed Web of Science ®Google Scholar
• RushRSDerbyPLSmithDMMicroheterogeneity of erythropoietin carbohydrate structureAnal Chem1995678144214527741215
   PubMed Web of Science ®Google Scholar
• KissZElliottSJedynastyKTesarVSzegediJDiscovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impactEur J Clin Pharmacol201066433134020127232
   PubMed Web of Science ®Google Scholar
• TsudaEKawanishiGUedaMMasudaSSasakiRThe role of carbohydrate in recombinant human erythropoietinEur J Biochem199018824054112156701
   PubMedGoogle Scholar
• NarhiLOArakawaTAokiKHThe effect of carbohydrate on the structure and stability of erythropoietinJ Biol Chem19912663423022230261744097
   PubMed Web of Science ®Google Scholar
• EndoYNagaiHWatanabeYOchiKTakagiTHeat-induced aggregation of recombinant erythropoietin in the intact and deglycosylated states as monitored by gel permeation chromatography combined with a low-angle laser light scattering techniqueJ Biochem199211257007061478930
   PubMed Web of Science ®Google Scholar
• UchidaEMorimotoKKawasakiNIzakiYAbdu SaidAHayakawaTEffect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietinFree Radic Res19972733113239350435
   PubMed Web of Science ®Google Scholar
• GoocheeCFGramerMAndersenDBahrJRasmussenJRThe oligosaccharides of glycoproteins: factors affecting their synthesis and their influence on glycoprotein propertiesSikdarSKBrierMToddPFrontiers in Bioprocessing IIWashingtonAmerican Chemical Society1991199240
   Google Scholar
• StowersAWChen LhLHZhangYA recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparumProc Natl Acad Sci USA200299133934411752405
   PubMed Web of Science ®Google Scholar
• CasadevallNNatafJVironBPure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietinN Engl J Med2002346746947511844847
   PubMed Web of Science ®Google Scholar
• BennettCLLuminariSNissensonARPure red-cell aplasia and epoetin therapyN Engl J Med2004351141403140815459301
   PubMed Web of Science ®Google Scholar
• SchellekensHJiskootWEprex-associated pure red cell aplasia and leachatesNat Biotechnol200624661361416763579
   PubMed Web of Science ®Google Scholar
• ImperialiBO’ConnorSEEffect of N-linked glycosylation on glycopeptide and glycoprotein structureCurr Opin Chem Biol19993664364910600722
   PubMed Web of Science ®Google Scholar
• ElliottSChangDDelormeEIsolation and characterization of conformation sensitive antierythropoietin monoclonal antibodies: effect of disulfide bonds and carbohydrate on recombinant human erythropoietin structureBlood1996877271427228639887
   PubMed Web of Science ®Google Scholar
• FernandesAIGregoriadisGThe effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokineticsInt J Pharm20012171–221522411292557
   PubMed Web of Science ®Google Scholar
• HoCLLinYLChenWCRocchiRPiekTComparison of the immunogenicity of wasp venom peptides with or without carbohydrate moietiesToxicon19983612172219604295
   PubMed Web of Science ®Google Scholar
• EgrieJCBrowneJKDevelopment and characterization of novel erythropoiesis stimulating protein (NESP)Br J Cancer200184Suppl 131011308268
   PubMed Web of Science ®Google Scholar
• HiguchiMOh-edaMKuboniwaHTomonohKShimonakaYOchiNRole of sugar chains in the expression of the biological activity of human erythropoietinJ Biol Chem199226711770377091560005
   PubMed Web of Science ®Google Scholar
• FukudaMNSasakiHLopezLFukudaMSurvival of recombinant erythropoietin in the circulation: the role of carbohydratesBlood198973184892910371
   PubMed Web of Science ®Google Scholar
• SpivakJLHogansBBThe in vivo metabolism of recombinant human erythropoietin in the ratBlood198973190992462945
   PubMed Web of Science ®Google Scholar
• WidnessJAVeng-PedersenPSchmidtRLLoweLSKisthardJAPetersCIn vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheepJ Pharmacol Exp Ther19962793120512108968342
   PubMed Web of Science ®Google Scholar
• KindlerJEckardtKUEhmerBSingle-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failureNephrol Dial Transplant1989453453492505184
   PubMed Web of Science ®Google Scholar
• MacdougallICRobertsDEColesGAWilliamsJDClinical pharmacokinetics of epoetin (recombinant human erythropoietin)Clin Pharmacokinet1991202991132029809
   PubMed Web of Science ®Google Scholar
• JensenJDJensenLWMadsenJKPoulsenLThe metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteersEur J Haematol19955421111167698293
   PubMed Web of Science ®Google Scholar
• DinkelaarRBEngelsEYHartAASchoemakerLPBoschEChamuleauRAMetabolic studies on erythropoietin (EP): II. The role of liver and kidney in the metabolism of EpExp Hematol1981977968037318981
   PubMed Web of Science ®Google Scholar
• ClarenburgRAsialoglycoprotein receptor is uninvolved in clearing intact glycoproteins from rat bloodAm J Physiol19832443G247G2536187222
   PubMed Web of Science ®Google Scholar
• IshibashiSHammerREHerzJAsialoglycoprotein receptor def-ciency in mice lacking the minor receptor subunitJ Biol Chem19942694527803278067961705
   PubMed Web of Science ®Google Scholar
• TozawaRIshibashiSOsugaJAsialoglycoprotein receptor deficiency in mice lacking the major receptor subunit. Its obligate requirement for the stable expression of oligomeric receptorJ Biol Chem200127616126241262811278827
   PubMed Web of Science ®Google Scholar
• SawyerSTKrantzSBGoldwasserEBinding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cellsJ Biol Chem198726212555455623032937
   PubMed Web of Science ®Google Scholar
• GrossAWLodishHFCellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP)J Biol Chem200628142024203216286456
   PubMed Web of Science ®Google Scholar
• ChapelSVeng-PedersenPHohlRJSchmidtRLMcGuireEMWidnessJAChanges in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathwayJ Pharmacol Exp Ther2001298282082411454947
   PubMed Web of Science ®Google Scholar
• Veng-PedersenPChapelSAl-HunitiNHPharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablationBiopharm Drug Dispos200425414915615108217
   PubMed Web of Science ®Google Scholar
• HartleyCElliottSBegleyCGKinetics of haematopoietic recovery after dose-intensive chemo/radiotherapy in mice: optimized erythroid support with darbepoetin alphaBr J Haematol2003122462363612899718
   PubMed Web of Science ®Google Scholar
• GlaspyJHenryDPatelREffects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfaEur J Cancer20054181140114915911237
   PubMed Web of Science ®Google Scholar
• AgoramBAokiKDoshiSInvestigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: nonerythropoietin receptor-mediated pathways may play a major roleJ Pharm Sci20099862198221118837016
   PubMed Web of Science ®Google Scholar
• FlahartyKKClinical pharmacology of recombinant human erythropoietin (r-HuEPO)Pharmacotherapy1990102(Pt 2)9S14S2345710
   PubMed Web of Science ®Google Scholar
• ElliottSLorenziniTAsherSEnhancement of therapeutic protein in vivo activities through glycoengineeringNat Biotechnol200321441442112612588
   PubMed Web of Science ®Google Scholar
• SinclairAMElliottSGlycoengineering: the effect of glycosylation on the properties of therapeutic proteinsJ Pharm Sci20059481626163515959882
   PubMed Web of Science ®Google Scholar
• BauseEStructural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probesBiochem J198320923313366847620
   PubMed Web of Science ®Google Scholar
• KornfeldRKornfeldSAssembly of asparagine-linked oligosaccharidesAnnu Rev Biochem1985546316643896128
   PubMed Web of Science ®Google Scholar
• GavelYvon HeijneGSequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineeringProtein Eng1990354334422349213
   PubMedGoogle Scholar
• ApweilerRHermjakobHSharonNOn the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT databaseBiochim Biophys Acta1999147314810580125
   PubMed Web of Science ®Google Scholar
• ElliottSChangDDelormeEErisTLorenziniTStructural requirements for additional N-linked carbohydrate on recombinant human erythropoietinJ Biol Chem200427916168541686214757769
   PubMed Web of Science ®Google Scholar
• ImperialiBHendricksonTLAsparagine-linked glycosylation: specificity and function of oligosaccharyl transferaseBioorg Med Chem1995312156515788770382
   PubMed Web of Science ®Google Scholar
• Van den SteenPRuddPMDwekRAVan DammeJOpdenakkerGCytokine and protease glycosylation as a regulatory mechanism in infam-mation and autoimmunityAdv Exp Med Biol19984351331439498072
   PubMed Web of Science ®Google Scholar
• Hurtado-GuerreroRDorfmuellerHCvan AaltenDMMolecular mechanisms of O-GlcNAcylationCurr Opin Struct Biol200818555155718822376
   PubMed Web of Science ®Google Scholar
• EgrieJCBrowneJKDevelopment and characterization of novel erythropoiesis stimulating protein (NESP)Nephrol Dial Transplant200116Suppl 331311402085
   PubMed Web of Science ®Google Scholar
• ElliottSEgrieJBrowneJControl of rHuEPO biological activity: the role of carbohydrateExp Hematol200432121146115515588939
   PubMed Web of Science ®Google Scholar
• EgrieJCDwyerEBrowneJKHitzALykosMADarbepoetin alfa has a longer circulating half-life and greater in vivo potency than recom-binant human erythropoietinExp Hematol200331429029912691916
   PubMed Web of Science ®Google Scholar
• SasuBJHartleyCSchultzHComparison of epoetin alfa and darbepoetin alfa biological activity under different administration schedules in normal miceActa Haematol2005113316317415870486
   PubMed Web of Science ®Google Scholar
• CocciaMACookeKStoneyGNovel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic infammatory disease in a rodent modelExp Hematol200129101201120911602322
   PubMed Web of Science ®Google Scholar
• MacdougallICGraySJElstonOPharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patientsJ Am Soc Nephrol199910112392239510541299
   PubMed Web of Science ®Google Scholar
• SmallingRFooteMMolineuxGSwansonSJElliottSDrug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledgeBiotechnol Annu Rev20041023725015504708
   PubMedGoogle Scholar
• WideLWikstromBErikssonKA new principle suggested for detection of darbepoetin-alpha (NESP) dopingUps J Med Sci2003108322923815000461
   PubMed Web of Science ®Google Scholar
• ElliottSGlycoengineering of ErythropoietinPost-Translational Modification of Protein BiopharmaceuticalsWeinheim, GermanyWiley-Blackwell2009295317
   Google Scholar
• de BoerRClemensMRenczesGPhase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignanciesMed Oncol20112841210121721046285
   PubMed Web of Science ®Google Scholar
• MacdougallICCERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemiaCurr Hematol Rep20054643644016232379
   PubMedGoogle Scholar
• HaselbeckABailonPPahlkeWThe discovery and characterization of CERA, an innovative agent for the treatment of anemiaBlood2002100Abstract 857227A
   Google Scholar
• FishbaneSTareNPillJHaselbeckAPreclinical pharmacodynamics and pharmacokinetics of CERA (Continuous Erythropoietin Receptor Activator), an innovative erythropoietic agent for anemia management in patients with kidney diseaseJ Am Soc Nephrol200314Abstract SA-FC 12327A
   Google Scholar
• MacdougallICRobsonROpatrnaSPharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (CERA) in patients with chronic kidney diseaseClin J Am Soc Nephrol2006161211121517699350
   PubMed Web of Science ®Google Scholar
• CurranMPMcCormackPLMethoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney diseaseDrugs20086881139115618484803
   PubMed Web of Science ®Google Scholar
• MolineuxGThe design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta)Curr Pharm Des200410111235124415078138
   PubMed Web of Science ®Google Scholar
• MacdougallICBailonPTareNCERA (Continuous Erythropoiesis Receptor Activator) for the treatment of renal anemia: an innovative agent with unique receptor binding characteristics and prolonged serum half-lifeJ Am Soc Nephrol200314Abstract SU-PO1063479A
   Google Scholar
• El-KomyMHSchmidtRLWidnessJAVeng-PedersenPDifferential pharmacokinetic analysis of in vivo erythropoietin receptor interaction with erythropoietin and continuous erythropoietin receptor activator in sheepBiopharm Drug Dispos201132527628821678432
   PubMed Web of Science ®Google Scholar
• BethencourtVMerck joins the biotech gameNat Biotech2009272104104
   Google Scholar
• HamiltonSRDavidsonRCSethuramanNHumanization of yeast to produce complex terminally sialylated glycoproteinsScience200631357921441144316960007
   PubMed Web of Science ®Google Scholar
• DoreyEMerck ditches biogenericNat Biotech2010287636636
   Google Scholar
• WrightonNCFarrellFXChangRSmall peptides as potent mimetics of the protein hormone erythropoietinScience199627352744584648662529
   PubMed Web of Science ®Google Scholar
• BarboneFPJohnsonDLFarrellFXNew epoetin molecules and novel therapeutic approachesNephrol Dial Transplant199914Suppl 2808410334672
   PubMed Web of Science ®Google Scholar
• WrightonNCBalasubramanianPBarboneFPIncreased potency of an erythropoietin peptide mimetic through covalent dimerizationNat Biotechnol19971512126112659359108
   PubMed Web of Science ®Google Scholar
• Bouman-ThioEFransonKMillerBA phase I, single and fractionated, ascending-dose study evaluating the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of an erythropoietin mimetic antibody fusion protein (CNTO 528) in healthy male subjectsJ Clin Pharmacol200848101197120718812609
   PubMed Web of Science ®Google Scholar
• BugelskiPJCapocasaleRJMakropoulosDCNTO 530: molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in miceJ Biotechnol20081341–217118018242752
   PubMed Web of Science ®Google Scholar
• SathyanarayanaPHoudeEMarshallDCNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast poolsBlood2009113204955496219264917
   PubMed Web of Science ®Google Scholar
• FanQLeutherKKHolmesCPPreclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemiaExp Hematol200634101303131116982323
   PubMed Web of Science ®Google Scholar
• DossSSchillerBPeginesatide: a potential erythropoiesis stimulating agent for the treatment of anemia of chronic renal failureNephrol Nurs J201037661762621290916
   PubMed Web of Science ®Google Scholar
• BesarabAZeigSNMartinERAn open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patientsBMC Nephrol2012139522935486
   PubMed Web of Science ®Google Scholar
• FishbaneSSchillerBLocatelliFPeginesatide in patients with anemia undergoing hemodialysisN Engl J Med2013368430731923343061
   PubMed Web of Science ®Google Scholar
• MacdougallICProvenzanoRSharmaAPeginesatide for anemia in patients with chronic kidney disease not receiving dialysisN Engl J Med2013368432033223343062
   PubMed Web of Science ®Google Scholar
• WoodburnKWFanQWinslowSHematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia modelExp Hematol20073581201120817662888
   PubMed Web of Science ®Google Scholar
• MacdougallICRossertJCasadevallNA peptide-based erythropoietin-receptor agonist for pure red-cell aplasiaN Engl J Med2009361191848185519890127
   PubMed Web of Science ®Google Scholar
• ElliottSLorenziniTYanagiharaDChangDElliottGActivation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodiesJ Biol Chem19962714024691246978798737
   PubMed Web of Science ®Google Scholar
• SchneiderHChaovapongWMatthewsDJHomodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursorsBlood19978924734829002949
   PubMed Web of Science ®Google Scholar
• LiuZStollVSDevriesPJA potent erythropoietin-mimicking human antibody interacts through a novel binding siteBlood200711072408241317620453
   PubMed Web of Science ®Google Scholar
• LacySEDeVriesPJXieNFungELesniewskiRRReillyEBThe potency of erythropoietin-mimic antibodies correlates inversely with affinityJ Immunol200818121282128718606682
   PubMed Web of Science ®Google Scholar
• ZhangHWilsonIALernerRASelection of antibodies that regulate phenotype from intracellular combinatorial antibody librariesProc Natl Acad Sci USA201210939157281573323019357
   PubMed Web of Science ®Google Scholar
• SytkowskiAJLunnEDDavisKLFeldmanLSiekmanSHuman erythropoietin dimers with markedly enhanced in vivo activityProc Natl Acad Sci USA1998953118411889448306
   PubMed Web of Science ®Google Scholar
• SytkowskiAJLunnEDRisingerMADavisKLAn erythropoietin fusion protein comprised of identical repeating domains exhibits enhanced biological propertiesJ Biol Chem199927435247732477810455149
   PubMed Web of Science ®Google Scholar
• BitontiAJDumontJALowSCPulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathwayProc Natl Acad Sci USA2004101269763976815210944
   PubMed Web of Science ®Google Scholar
• DumontJABitontiAJClarkDEvansSPickfordMNewmanSPDelivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathwayJ Aerosol Med200518329430316181004
   PubMedGoogle Scholar